Stoneridge Investment Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Stoneridge Investment Partners's AMGN Position: Q1 2022 in Review
Stoneridge Investment Partners sold out of Amgen (AMGN) in Q1 2022, closing a stake of 5,838 shares — an estimated $1.31M sold.
Stoneridge Investment Partners first reported a position in AMGN in Q2 2013 and held it in 14 quarters. The position peaked at $8.65M in Q4 2013. 2,338 funds tracked by Wall St. Rank hold AMGN as of Q1 2022.
- Stoneridge Investment Partners reported no remaining Amgen position as of Q1 2022 after selling out during the quarter.
- Stoneridge Investment Partners sold 5,838 Amgen shares in Q1 2022, an estimated $1.31M.
- Stoneridge Investment Partners first reported a position in Amgen in Q2 2013 and held it in 14 quarters.
- Stoneridge Investment Partners's Amgen position peaked at $8.65M in Q4 2013.
- 2,338 funds tracked by Wall St. Rank held Amgen as of Q1 2022.
Based on Stoneridge Investment Partners's 13F filing for Q1 2022, filed 26 Apr 2022.